Optimization of lung function before pulmonary resection: pulmonologists' perspectives

Thoracic Surgery Clinics
Aymarah M Robles, Deborah Shure

Abstract

Many risk factors for morbidity and mortality with lung resection have been identified. Factors such as age, gender, and cancer stage cannot be altered, but lung function can be optimized by treating COPD or asthma with bronchodilators, corticosteroids, or antibiotics (when indicated) and by inspiratory muscle training. Although smoking cessation 2 months in advance of surgery may not be feasible, cessation nevertheless should be encouraged because it may decrease postoperative inflammation and in the long-term may decrease the risk of recurrence. In addition, morbidity and mortality can be minimized by careful patient selection using lung scanning or CT to determine predicted postoperative functions (FEV1% and DLco%) and some form of exercise testing, such as cardiopulmonary exercise testing or simple stair climbing. When the risk of surgery is high, any benefit from possible cure must be weighed against the risk of long-term disability or death. Although much data are available to guide clinicians in these decisions, there still is no one test that provides the answer in individual cases. The art and science of medicine must merge at this point.

References

Apr 1, 1989·The American Review of Respiratory Disease·J MarkosK E Finucane
May 1, 1987·The Medical Clinics of North America·G M Tisi
May 1, 1982·The American Review of Respiratory Disease·N C ColmanR L Pardy
Mar 1, 1981·The American Journal of Medicine·R A GaribaldiN L Pace
Sep 1, 1995·The Annals of Thoracic Surgery·V RaoF G Pearson
May 1, 1995·American Journal of Respiratory and Critical Care Medicine·C T BolligerM Tamm
Jan 1, 1994·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·K S NaunheimD R Judd
Feb 1, 1995·The Journal of Thoracic and Cardiovascular Surgery·M K FergusonR Mick
Oct 1, 1994·American Journal of Respiratory and Critical Care Medicine·R J PierceC E Barter
May 1, 1996·The Annals of Thoracic Surgery·P PateD S Weiman
Mar 1, 1996·The European Respiratory Journal·C T BolligerA P Perruchoud
Mar 1, 1997·The Journal of Thoracic and Cardiovascular Surgery·P WeinerY Greiff
Nov 14, 1997·The Annals of Thoracic Surgery·K R LarsenB N Petersen
Sep 3, 1998·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·S PagniR B Ponn
Jan 7, 1999·The European Respiratory Journal·J RibasR Rodriguez-Roisin
Jun 4, 1999·The Annals of Thoracic Surgery·J WangM K Ferguson
May 2, 2000·The Journal of Thoracic and Cardiovascular Surgery·R YamamotoT Tojo
Jun 15, 2000·The European Respiratory Journal·M H BrutscheJ M Tschopp
Oct 13, 2000·American Journal of Respiratory and Critical Care Medicine·J S WangB L Graham
Nov 18, 2000·The Annals of Thoracic Surgery·A BernardJ P Favre
Mar 17, 2001·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·G VarelaN Novoa
Mar 28, 2001·The Annals of Thoracic Surgery·R T JagoeG J Gibson
Jul 21, 2001·The New England Journal of Medicine·P B BachC B Begg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery
Richard BerrisfordEuropean Association of Cardiothoracic Surgeons
Clinics in Chest Medicine
Macé M SchuurmansC T Bolliger
© 2021 Meta ULC. All rights reserved